| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/23/2003 | EP0836615B1 New thrombin inhibitors, their preparation and use |
| 04/23/2003 | EP0784603B1 Racemisation of precursors to levobupivacaine and analogues thereof |
| 04/23/2003 | CN1413194A Inhibition of polymerization of unsaturated monomers |
| 04/23/2003 | CN1413191A Method for production of N-alkenyl amides |
| 04/23/2003 | CN1413189A Benzamidine derivatives |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/22/2003 | US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/22/2003 | US6552176 Salt forms of 6-n-butylamino-6-deoxy-α-L-sorbofuranose |
| 04/22/2003 | US6552090 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof |
| 04/22/2003 | US6552079 Integrin antagonists |
| 04/22/2003 | US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 04/22/2003 | US6552046 Cisapride |
| 04/22/2003 | US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 04/22/2003 | US6552040 Use of nitroxides in wound healing and in the prevention of photodamage |
| 04/22/2003 | US6552032 Opiate compounds, methods of making and methods of use |
| 04/22/2003 | CA2222713C Composition comprising d-threo-methylphenidate and another drug |
| 04/17/2003 | WO2003032072A2 Crosslinkable monomers for novel nonlinear optical polymers |
| 04/17/2003 | WO2003031433A1 A process for preparing 4-(hydroxy)-[1,4']bipiperidinyl-l'carboxylic acid tert-butyl ester |
| 04/17/2003 | WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 04/17/2003 | WO2003031412A1 Piperidine compounds as muscarinic antagonists |
| 04/17/2003 | WO2003031411A2 Direct resolution of racemic threo-methylphenidate hydrochloride |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073838 3-alkyl-3-phenyl-piperidines |
| 04/17/2003 | US20030073721 Central nervous system disorders; Alzheimer's disease; genetic engineering |
| 04/17/2003 | US20030073719 Chiral salt resolution |
| 04/17/2003 | US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 04/17/2003 | US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production |
| 04/17/2003 | US20030073690 Controlling pain in mammals |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030073681 Mammal cellular receptors; therapy for psychological disorders, analgesics, hypotensive agents |
| 04/17/2003 | US20030073670 Aqueous solution |
| 04/17/2003 | CA2462861A1 Piperidine compounds as muscarinic antagonists |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/16/2003 | EP1302462A1 Sulfone derivatives, process for their production and use thereof |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1301506A1 Cyclic amino acid derivatives |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1181017B1 Metalloprotease inhibitors |
| 04/16/2003 | EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/16/2003 | EP0773955B1 New thrombin inhibitors, their preparation and use |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411443A Method for producing N-alkenyl amides |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1411374A Substituted piperazine and piperidine calcium channel blockers |
| 04/16/2003 | CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548504 Compounds |
| 04/15/2003 | US6548498 Substituted indan derivatives |
| 04/15/2003 | US6548471 Perfluoroaminoperfluoroalkyl hydrocarbyl ethers such as perfluoro(3-(piperidin-1-yl)propyl) methyl ether; for solvent cleaning applications, with low ozone depletion potential |
| 04/15/2003 | CA2047375C Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis |
| 04/12/2003 | CA2407214A1 Method of monitoring neuroprotective treatment |
| 04/10/2003 | WO2003029340A2 Fluorescent pigment composition |
| 04/10/2003 | WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists |
| 04/10/2003 | WO2003029232A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029215A1 4[piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028725A1 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands |
| 04/10/2003 | WO2003007069A3 Novel nonlinear optical polymers |
| 04/10/2003 | WO2002078639A3 A method of treating proliferative diseases using eg5 inhibitors |
| 04/10/2003 | WO2002048109A8 N-alkoxy-4,4-dioxy-polyalkyl-piperidines as radical polymerization initiators |
| 04/10/2003 | WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 04/10/2003 | US20030069429 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 04/10/2003 | US20030069418 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/10/2003 | US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them |
| 04/10/2003 | US20030069285 Hypotensive agents |
| 04/10/2003 | US20030069276 Viricides; aids therapy |
| 04/10/2003 | US20030069274 Pharmaceutically active compounds and methods of use |
| 04/10/2003 | US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid |
| 04/10/2003 | US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders |
| 04/10/2003 | US20030069252 Viricides; antiinflammatory agents |
| 04/10/2003 | US20030069250 Anticoagulants |
| 04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
| 04/10/2003 | US20030069242 3-arylphenyl sulfide derivative and insecticide and miticide |
| 04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
| 04/10/2003 | CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462110E Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/10/2003 | CA2460168A1 4¬piperidin-4-yliden-(3-carbamoylphenyl)methyl| benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/09/2003 | EP1300395A1 4-substituted piperidine compound |
| 04/09/2003 | EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
| 04/09/2003 | EP1299357A1 Novel compounds |
| 04/09/2003 | EP1299356A1 Novel compounds |